Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Oct 14, 2009; 15(38): 4816-4822
Published online Oct 14, 2009. doi: 10.3748/wjg.15.4816
Published online Oct 14, 2009. doi: 10.3748/wjg.15.4816
Treatment | Viable cells (%) | ALT (IU/L) | AST (IU/L) |
Cell control | 93.88 ± 0.81 | 18.70 ± 0.46 | 21.53 ± 0.63 |
Toxicant (1 mol/L CCl4) | 33.06 ± 114 | 50.20 ± 0.61 | 57.50 ± 0.94 |
Std Liv52 (250 μL/mL) | 85.84 ± 1.19 (86.7)a | 19.46 ± 0.35 (97.59)a | 24.10 ± 0.37 (92.85)a |
ALE (250 μg/mL) | 57.63 ± 1.58 (40.39)a | 41.33 ± 0.62 (28.16)a | 44.53 ± 1.25 (36.05)a |
ALE (500 μg/mL) | 77.60 ± 0.57 (73.72)a | 38.50 ± 0.45 (37.14)a | 32.80 ± 0.65 (68.66)a |
ALE (1000 μg/mL) | 81.24 ± 1.67 (79.20)a | 22.23 ± 0.50 (88.48)a | 27.33 ± 0.69 (83.87)a |
-
Citation: Pradeep HA, Khan S, Ravikumar K, Ahmed MF, Rao MS, Kiranmai M, Reddy DS, Ahamed SR, Ibrahim M. Hepatoprotective evaluation of
Anogeissus latifolia :In vitro andin vivo studies. World J Gastroenterol 2009; 15(38): 4816-4822 - URL: https://www.wjgnet.com/1007-9327/full/v15/i38/4816.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.4816